Options Bulls Just Banked on LLY Stock's Latest Rally

Analysts have started to raise their LLY price targets

Deputy Editor
Mar 4, 2019 at 3:13 PM
facebook twitter linkedin

Subscribers to Schaeffer's Weekend Trader Series service doubled their money with the Eli Lilly And Co (NYSE:LLY) April 110 call. Here's a quick look at why we expected a big upside move from the pharmaceutical stock, and how the profitable options trade unfolded.

When we entered the position on Monday, Jan. 7, Eli Lilly was sitting 50% above its 2018 lows from February and March -- just north of the $112 level. The shares had pulled back in December, but found a floor at the $109 area, which coincided with its post-earnings breakout from a channel of lower highs back in November. With multiple levels of support in place, more upside from LLY looked promising. 

And although Eli Lilly stock was up 31% year-over-year when we recommended the position, analyst sentiment was still pessimistic. Of the 17 brokerages covering the equity at the time, nine rated it a "hold" or worse. Furthermore, the stock's consensus 12-month price target of $118.19 was only a 3.7% premium to the previous Friday's close. This indicated that bullish analyst attention might serve as tailwinds in the coming months.

In the wake of our recommendation, LLY stock extended its run higher. Analysts began to take note of this impressive price action, too, with the stock receiving post-earnings price-target hikes from BMO, Cantor Fitzgerald and Credit Suisse. In fact, the security only finished two weeks lower since Jan. 6, allowing us to close our position on Tuesday, Feb. 27, and lock in a 100% profit.

LLY Chart Feb 28

Begin the New Year With Schaeffer's 7 FREE 2022 Stock Picks!



Special Offers from Schaeffer's Trading Partners